Phase 1 Acute-On-Chronic Liver Failure Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
Acute-On-Chronic Liver FailureChronic Liver Failure
RenJi Hospital10 enrolled1 locationNCT05727722
Recruiting
Phase 1Phase 2
Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients
Acute-On-Chronic Liver Failure
Sun Yat-sen University90 enrolled1 locationNCT06740149
Recruiting
Phase 1Phase 2
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Acute-On-Chronic Liver Failure
Beijing 302 Hospital150 enrolled1 locationNCT05985863